A flow-basedmicrosystem was designed to investigate CD4+ T cell activationin response to different IL-6 gradients in an under-control 3D culture.The study found that cancer cells’ response to varying IL-6concentrations was dynamic and dose-sensitive, with immune cell migrationrates showing sensitivity to the IL-6 gradient. Here, IL6 is linked to cancer.